🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Next-generation sequencing-based #GeneticTesting offers a way to identify genetic markers early, enabling timely intervention and better management of #ParkinsonDisease. medicalxpress.com/news/2025-04-e…

Amazing work from our Tafesse affiliate lab team and contributors, who have been able to expand on their earlier paper. These results yield new insights into factors that influence envelope protein functions. Read the full article here: pmc.ncbi.nlm.nih.gov/articles/PMC12…

Our Sacha and Hansen lab teams with contributors, have been investigating Leronlimab as a treatment option for people living with multidrug-resistant HIV-1. Great work by all! Read the full article here: pubmed.ncbi.nlm.nih.gov/39972543/

Researchers at OHSU News have created a new kind of nanoparticle that could make ultrasound-based cancer treatments more effective and safer, while also helping prevent tumors from coming back. #OHSUResearch: bit.ly/458TDT8

In a recently published paper, members of the Wilder Lab at VGTI and collaborators, have developed a transgenic P. cynomolgi parasite expressing a key P. vivax protein, allowing for the study of anti-vivax interventions in NHPs. Read the full article here:

In this newly published paper, members of our Wilder Lab with collaborators, explore whether host-driven TPD can degrade Plasmodium PVM proteins. It highlights the challenges of developing TPD approaches against novel targets and offers insights for advancing this therapeutic

An OHSU News lab is working on a universal flu vaccine that could, in theory, protect people from the virus for life. #Research on nonhuman primates is critical for being able to replicate how complex systems respond to new therapies. oregonlive.com/opinion/2025/0…

Join us for the next Health Equity and Anti-racism Talks (HEART) at OHSU News! "Original Sins: The (Mis)education of Black and Native Children and the Construction of American Racism" on Wednesday, 6/18 from 5:30 – 7 p.m. with Dr. Eve L. Ewing. ohsu.edu/diversity-equi…

.Curtis Lachowiez collaborated on research with CU Cancer Center that identified gene mutations and cell maturity as key factors in #AML drug resistance. The study, published in AACR, analyzed data from 678 #AML patients: bit.ly/3SsMHZE

A new Science #Immunology study describes a previously unknown inborn error of immunity in patients with #tuberculosis due to a rare inherited deficiency in the lymphocyte surface receptor LY9 in T helper 1 memory cells. scim.ag/4mC4fQP

Excited to share our latest preprint! Using integrated global lipidomics and proteomics, we show that SARS-CoV-2 variants induce conserved changes in host lipid metabolism pathways. OHSU News Pacific Northwest National Laboratory biorxiv.org/content/10.110…

Congratulations to our Caposio lab team and their contributors! This peer-reviewed study designed an RNA sequencing study to compare the transcriptional profile of HCMV infection in the presence and absence of UL135 and UL138 genes. Read the full article here:

It’s finally out! Started this project as a PhD student in the Joost Holthuis’s lab & now it’s finished by my PhD student. Full-circle moment and the end of an era. 😊 Huge thanks to Gaelen and everyone who made this happen. OHSU News Pacific Northwest National Laboratory #lipid pubmed.ncbi.nlm.nih.gov/40473211/

Congratulations to our Estes lab team and their contributors, on the recent publishing of a new paper! Their findings demonstrate that cell activation persists in the brain of VS PWH and is associated with HIV DNA in the brain and may contribute to neuropathology. Read the full

New #OHSUResearch provides a new understanding of the αSyn protein’s dual role and context to long-standing observations that people with #ParkinsonsDisease are significantly more likely to develop #melanoma, and vice versa. insideprecisionmedicine.com/topics/precisi… cc: OHSU Knight Cancer Institute

Congratulations to our Picker and Hansen Lab teams and contributors, for the recent publication on their SIV/HIV study! Neutralizing antibodies and MHC-E-restricted CD8+ T cells have shown the ability to protect against the simian counterpart of HIV, SIV, in rhesus macaques.

Roughly 11% of children and 6% of adults in the U.S are currently diagnosed with #ADHD—rates that are significantly higher than those reported in most other countries. gizmodo.com/why-are-adhd-r…

“Ten years ago, we had an opportunity to reshape cancer care in our region and have global impact. Today we continue working toward establishing OHSU as one of our country’s best academic health centers.” - Steve Stadum, OHSU News interim president: bit.ly/4nhvEb9

Congratulations to our DeFilippis Lab! This recent publication revealed demonstrable differences between their agonists in potency, transcriptomes, cytokine secretion profiles, immune cell trafficking, and antigen-directed humoral and cell mediated immune responses. Read the

In this recently published paper, our Axthelm affiliate lab team with our Hirsch and Streblow lab teams and their contributors, show the ZIKV-TH strain MU1-2017 behaves similarly to the ZIKV-PR strain and it provides evidence of in-utero infection with an additional contemporary